These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 20965606)

  • 21. Inhibition of DNA synthesis in mouse epidermis by topical imiquimod is dependent on opioid receptors.
    McLaughlin PJ; Rogosnitzky M; Zagon IS
    Exp Biol Med (Maywood); 2010 Nov; 235(11):1292-9. PubMed ID: 20975079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opioid growth factor-opioid growth factor receptor axis is a physiological determinant of cell proliferation in diverse human cancers.
    Zagon IS; Donahue RN; McLaughlin PJ
    Am J Physiol Regul Integr Comp Physiol; 2009 Oct; 297(4):R1154-61. PubMed ID: 19675283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endogenous opioid inhibition of proliferation of T and B cell subpopulations in response to immunization for experimental autoimmune encephalomyelitis.
    McLaughlin PJ; McHugh DP; Magister MJ; Zagon IS
    BMC Immunol; 2015 Apr; 16():24. PubMed ID: 25906771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose naltrexone targets the opioid growth factor-opioid growth factor receptor pathway to inhibit cell proliferation: mechanistic evidence from a tissue culture model.
    Donahue RN; McLaughlin PJ; Zagon IS
    Exp Biol Med (Maywood); 2011 Sep; 236(9):1036-50. PubMed ID: 21807817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of Tenon's capsule fibroblast cell proliferation by the opioid growth factor and the opioid growth factor receptor axis.
    Klocek MS; Sassani JW; Donahue RN; McLaughlin PJ; Zagon IS
    Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5054-61. PubMed ID: 20463323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progression of squamous cell carcinoma of the head and neck is associated with down-regulation of the opioid growth factor receptor.
    McLaughlin PJ; Zagon IS
    Int J Oncol; 2006 Jun; 28(6):1577-83. PubMed ID: 16685459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The expression and function of the OGF-OGFr axis - a tonically active negative regulator of growth - in COS cells.
    Zagon IS; Verderame MF; McLaughlin PJ
    Neuropeptides; 2003 Oct; 37(5):290-7. PubMed ID: 14607106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
    Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
    Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The OGF-OGFr axis utilizes the p16INK4a and p21WAF1/CIP1 pathways to restrict normal cell proliferation.
    Cheng F; McLaughlin PJ; Verderame MF; Zagon IS
    Mol Biol Cell; 2009 Jan; 20(1):319-27. PubMed ID: 18923142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opioid growth factor arrests the progression of clinical disease and spinal cord pathology in established experimental autoimmune encephalomyelitis.
    Campbell AM; Zagon IS; McLaughlin PJ
    Brain Res; 2012 Sep; 1472():138-48. PubMed ID: 22820301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of a relapse-remitting model of multiple sclerosis with opioid growth factor.
    Hammer LA; Zagon IS; McLaughlin PJ
    Brain Res Bull; 2013 Sep; 98():122-31. PubMed ID: 23973432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioid growth factor inhibits intimal hyperplasia in balloon-injured rat carotid artery.
    Zagon IS; Essis FM; Verderame MF; Healy DA; Atnip RG; McLaughlin PJ
    J Vasc Surg; 2003 Mar; 37(3):636-43. PubMed ID: 12618704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention and diminished expression of experimental autoimmune encephalomyelitis by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: Therapeutic implications for multiple sclerosis.
    Rahn KA; McLaughlin PJ; Zagon IS
    Brain Res; 2011 Mar; 1381():243-53. PubMed ID: 21256121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Under-expression of the opioid growth factor receptor promotes progression of human ovarian cancer.
    Donahue RN; McLaughlin PJ; Zagon IS
    Exp Biol Med (Maywood); 2012 Feb; 237(2):167-77. PubMed ID: 22328595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reepithelialization of the human cornea is regulated by endogenous opioids.
    Zagon IS; Sassani JW; McLaughlin PJ
    Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):73-81. PubMed ID: 10634604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opioid growth factor enhances tumor growth inhibition and increases the survival of paclitaxel-treated mice with squamous cell carcinoma of the head and neck.
    Jaglowski JR; Zagon IS; Stack BC; Verderame MF; Leure-duPree AE; Manning JD; McLaughlin PJ
    Cancer Chemother Pharmacol; 2005 Jul; 56(1):97-104. PubMed ID: 15791460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations in the opioid growth factor receptor in human cancers alter receptor function.
    Kren NP; Zagon IS; McLaughlin PJ
    Int J Mol Med; 2015 Jul; 36(1):289-93. PubMed ID: 26005722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of met-enkephalin on cell proliferation in different models of adrenocortical-cell growth.
    Malendowicz LK; Rebuffat P; Tortorella C; Nussdorfer GG; Ziolkowska A; Hochol A
    Int J Mol Med; 2005 May; 15(5):841-5. PubMed ID: 15806307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opioids and migration, chemotaxis, invasion, and adhesion of human cancer cells.
    Zagon IS; Rahn KA; McLaughlin PJ
    Neuropeptides; 2007 Dec; 41(6):441-52. PubMed ID: 17910895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The opioid growth factor-opioid growth factor receptor axis regulates cell proliferation of human hepatocellular cancer.
    Avella DM; Kimchi ET; Donahue RN; Tagaram HR; McLaughlin PJ; Zagon IS; Staveley-O'Carroll KF
    Am J Physiol Regul Integr Comp Physiol; 2010 Feb; 298(2):R459-66. PubMed ID: 19923357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.